Skip to main content

Table 2 KRAS and switch status of patients in Study 20020408

From: A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study

 

BSC (n = 232)

Panitumumab plus BSC (n = 231)

MT KRAS

100

84

WT KRAS

119

124

Unknown KRAS

13

23

MT KRAS switchers

77 (23 non-switchers)

-

WT KRAS switchers

91 (28 non-switchers)

-

Switchers with unknown KRAS

8

-

  1. Notes: BSC - Best Supportive Care; KRAS - Kirsten Rat Sarcoma Virus; MT - Mutant Type; WT - Wild Type
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us